Category:
Active Pharmaceutical Ingredients
CAS NO:
NA
Standard:
In-house Standards,
Pentoxifylline Sustained Release Tablets are oral dosage forms designed to modulate hemorheology via xanthine derivative activity. The core process involves controlled-release matrix technology to ensure steady plasma concentrations. Molecular formula: C13H18N4O3; CAS No.: 652-33-5.
Contraindicated in patients with recent cerebral hemorrhage or severe hepatic impairment. Store below 25°C in dry conditions. Strict adherence to dosing schedules is required to prevent hypotension risks.